Patients told that they may need drug stockpiles in light of a “no deal” Brexit

Representatives of the pharma industry and drug distributors have told a committee of MPs that patients should consider stockpiling their own drugs if a “no deal” Brexit scenario looks likely. The Guardian reported that the Commons health committee heard that no deal will be “catastrophic” for medicine supplies and could necessitate emergency powers. The ABPI

Continue Reading

NHS Scotland to fund new therapies for AML, Arthritis and others

The Scottish Medicines Consortium has endorsed NHS funding for four therapies that  new treatment options for acute myeloid leukaemia, Still’s disease, adrenal insufficiency and psoriatic arthritis. Pfizer’s Gemtuzumab ozogamicin was accepted for the treatment of acute myeloid leukaemia (AML), after being considered through the SMC’s Patient and Clinician Engagement (PACE) process. Current initial treatment for

Continue Reading